Clinical Trials in Michigan

Showing 4521-4540 of 16,154 trials

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

NCT03645681

The CSP-1001 study will evaluate the safety and effectiveness of the InnAVasc arteriovenous graft (AVG) when implanted in and used for hemodialysis in participants suffering from end stage renal failure (ESRD). The InnAVasc AVG is implanted and used similar to other standard of care dialysis grafts currently on the market. However, the InnAVasc AVG has been uniquely designed to potentially allow for immediate needle access (same day as implant surgery as opposed to 2-4 weeks of waiting), to potentially reduce excessive bleeding from the graft after dialysis, and it may provide protection from improper or missed needle cannulation attempts.

Kidney Failure, ChronicRenal Dialysis

W.L.Gore & Associates26 participantsStarted Jan 2019

San Diego, California, United States • Flint, Michigan, United States • Greenwood, Mississippi, United States +4 more locations

COMPLETEDNA62 miles

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

NCT00853632

The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards® PERIMOUNT Magna Mitral Valves in patients undergoing mitral valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.

Coronary Artery DiseaseMitral Valve RegurgitationMitral Valve Incompetence+1 more

Edwards Lifesciences329 participantsStarted Aug 2007

Sacramento, California, United States • Orlando, Florida, United States • Chicago, Illinois, United States +12 more locations

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Find Trials by Condition in Michigan

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

STEM-Parkinson's Disease

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Impairments That Affect Correct Inhaler Use in COPD

A Study of SEA-CD40 Given With Other Drugs in Cancers

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)

Adalimumab in JIA-associated Uveitis Stopping Trial

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors